Chargement en cours...
Tamoxifen induction of angiogenic factor expression in endometrium
Tamoxifen is the current therapy of choice for patients with oestrogen receptor positive breast cancer, and it is currently under evaluation as a prophylactic for women at high risk of developing the disease. However, tamoxifen is also known to induce proliferative changes in the endometrium increas...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2002
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2375303/ https://ncbi.nlm.nih.gov/pubmed/11875740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600157 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|